|
⚲
|
| Keyboard |
| Selick Harold E
✚
|
|
|---|---|
| CIK # | 0001287233 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001287233] | |
| 4 | [0001287233] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Selick Harold E | |
| Protagonist Therapeutics Inc | |
| Threshold Pharmaceuticals Inc | |
| PDL Biopharma Inc | |
| GYRE Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-03-26 | Option exercise | 24,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-03-26 | Option exercise | 24,000 | $12.88 | 309,120 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-03-26 | Sell | 24,000 | $105.00 | 2,520,000 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-09 | Option exercise | 14,299 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-09 | Option exercise | 14,299 | $4.21 | 60,199 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 3,762 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-02 | Grant | 2,695 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-04-28 | Option exercise | 10,725 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-04-28 | Option exercise | 10,725 | $1.16 | 12,441 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-01-02 | Grant | 5,130 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 6,584 | $0.00 | |
|
Threshold Pharmaceuticals Inc MTEM
Stock Option (right to buy) · derivative
|
2024-09-27 | Grant | 1,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2024-03-07 | Option exercise | 6,490 | $1.89 | 12,266 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2024-03-07 | Option exercise | 6,490 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 25,700 | $0.00 | |
|
Threshold Pharmaceuticals Inc MTEM
Stock Option (right to buy) · derivative
|
2023-10-27 | Grant | 1,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2023-04-10 | Option exercise | 6,196 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2023-04-10 | Option exercise | 6,196 | $0.87 | 5,391 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2023-01-16 | Grant | 30,000 | $0.00 | |
|
Threshold Pharmaceuticals Inc MTEM
Stock Option (right to buy) · derivative
|
2022-06-03 | Grant | 15,000 | $0.00 | |
| showing 20 of 76 most recent transactions | |||||